Operating Expenses Изменить Дата
Agios Pharmaceuticals USD 113.38M 5.08M 2023-12
Alnylam Pharmaceuticals USD 556.12M 19.46M 2023-12
Amgen USD 6.93B 2.11B 2023-12
Astellas Pharma JPY 386.93B 57.73B 2023-09
AstraZeneca USD 9.54B 578M 2023-09
Bayer EUR 13.94B 1.94B 2023-09
BioCryst Pharmaceuticals USD 98.66M 33.55M 2023-09
Bluebird Bio USD 97.12M 4.93M 2023-09
Bristol-Myers Squibb USD 9.62B 984M 2023-12
Eisai JPY 171.22B 309M 2023-09
Eli Lilly USD 6.97B 2.08B 2023-12
Exelixis USD 489.5M 97.5M 2023-09
Gilead Sciences USD 5.5B 1.08B 2023-12
GlaxoSmithKline GBP 6.2B 1.16B 2023-09
Incyte USD 826.07M 121.75M 2023-12
Ionis Pharmaceuticals USD 303.83M 14.26M 2023-12
J&J USD 16.57B 435M 2023-12
Merck USD 16.56B 6.35B 2023-12
Moderna USD 2.8B 1.04B 2023-12
Nektar Therapeutics USD 69.01M 2.09M 2023-09
Pfizer USD 20.8B 4.62B 2023-12
Roche Holding CHF 20.02B 5.04B 2023-06
Sarepta Therapeutics USD 380.16M 87.4M 2023-09
Takeda JPY 1.09T 202.38B 2023-09
Ultragenyx Pharmaceutical USD 249.44M 6.29M 2023-12



Mirati Therapeutics Операционные Расходы - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - Mar 2024.